Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
National Healthcare Properties acquisition has completed the acquisition of National Healthcare Properties, a healthcare services other business in New York, for $100 million. The company is focused on healthcare services other, operating in the healthcare sector with preferred equity securities including 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred stock. The National Healthcare Properties acquisition supports healthcare M&A activity through other acquisition of its own preferred shares, targeting NY acquisitions and other acquisition structures. The healthcare deals NY filing is an issuer tender offer under SEC Schedule TO, offering $22.50 per share in cash for up to $100 million aggregate purchase price.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026